//
sign in
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
Get insights into the safety and efficacy of #MRAs in #HeartFailure with reduced, mildly reduced, and preserved ejection fractions, including in the context of kidney disease. 👉️ buff.ly/lBM631W #CardioSky
1d
Insights into the safety and efficacy of mineralocorticoid receptor antagonists in heart failure with reduced, mildly reduced, and preserved ejection fractions, including in the context of kidney…
www.springermedicine.com
Mineralocorticoid receptor antagonists for the treatment of heart failure and kidney disease: a state-of-the-art review
Springer Medicine